ICU Medical Inc

In a Stage 2 Advancing corrective reset that has resumed its upcycle, ICUI is pulling back into its rising EMAs, offering a tactical entry ahead of continuation. The active Lockout Rally pattern signals strong demand fueled by short covering and positioning asymmetry. EMAs remain stacked and rising, and no exhaustion is evident despite overbought context. Key risks include a failure to hold the short-term EMAs and resistance at recent highs that could stall the advance.

• ↑Q1 revenue $526M with 1% organic growth despite deconsolidation headwinds.
• ↑FY2026 free cash flow guidance of ~$150M underscores strong cash generation.
• ↓Tariffs expected to add $25–30M in FY25 expenses, squeezing gross margins.